Evidence map›Paper›PMID 40423368›Full record

ArticleTropical medicine and infectious disease2025

Angela Copete, Mariana Herrera, Camilo Suarez-Ariza, Zipporah Gitau, Maria Arango-Uribe, Rotem Keynan, Camila Oda, Ameeta E Singh, Stuart Skinner, Cara Spence and 11 more

Abstract read
In one paragraph

Article in Tropical medicine and infectious disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Mycoplasma Genitalium - Where are we at?Current HIV/AIDS reports · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Angela CopeteDepartment of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.
Mariana HerreraDepartment of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.ORCID 0000-0002-7482-2010
Camilo Suarez-ArizaDepartment of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.
Zipporah GitauDepartment of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.
Maria Arango-UribeDepartment of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.
Rotem KeynanDepartment of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.
Camila OdaDepartment of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.
Ameeta E SinghDepartment of Medicine, University of Alberta, Edmonton, AB T6G 2R3, Canada.ORCID 0000-0003-2627-3704
Stuart SkinnerDepartment of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5A2, Canada.
Cara SpenceDepartment of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5A2, Canada.
Will RiañoGrupo Bacterias & Cáncer, Facultad de Medicina, Universidad de Antioquia, Medellin 050010, Colombia.ORCID 0009-0005-0068-5921
Lauren J MacKenzieDepartment of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.ORCID 0000-0002-4794-9120
Ken KasperDepartment of Internal Medicine, University of Manitoba, Winnipeg, MB R3T 2N2, Canada.
Laurie IrelandManitoba HIV Program, Winnipeg, MB R3G 0X2, Canada.
Irene MartinStreptococcus and STI Unit, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada.
Jared BullardDepartment of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.
Lucelly LopezSchool of Medicine, Universidad Pontificia Bolivariana (UPB), Medellin 101001, Colombia.ORCID 0000-0002-1534-520X
Diana MarinSchool of Medicine, Universidad Pontificia Bolivariana (UPB), Medellin 101001, Colombia.ORCID 0000-0002-4715-8388
Margaret Haworth-BrockmanDepartment of Community Health Sciences, University of Manitoba, Winnipeg, MB R3T 2N2, Canada.
Yoav KeynanDepartment of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.ORCID 0000-0003-4948-4707
Zulma Vanessa RuedaDepartment of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.ORCID 0000-0001-6342-1812

Funding

Canada Research Chairs Program 950-232963CIHR SR7-190790CIHR Research Excellence, Diversity, and Independence (REDI) Early Career Transition Award ED6-190717CIHR Research Excellence, Diversity, and Independence (REDI) Early Career Transition Award OS3 -190782
6 · The paper itself

Abstract

backgroundWe aimed to describe trends in

methodsEcological study and a scoping review. We collected publicly available data published by the governments of all Canadian provinces and territories. We also systematically searched PubMed, Medline, Embase, and grey literature using the keywords '

resultsNational or provincial surveillance systems for

conclusions

Indexed as

Canadafluoroquinolone resistance mutationsmacrolide resistance mutationsMycoplasma genitaliumscoping review

Identifiers

PMID40423368
PMCPMC12115471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.